Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Provectus Biopharmaceuticals Inc (PVCT)

Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy GlobeNewswire - Thu Oct 9, 7:00AM CDT

KNOXVILLE, Tenn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the publication of independent preclinical...

PVCT : 0.0599 (-10.86%)
Provectus Biopharmaceuticals Initiates Preclinical Study of Oral PV-10 in Bladder Cancer GlobeNewswire - Mon Sep 29, 7:00AM CDT

KNOXVILLE, Tenn., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the start of a preclinical study of its...

PVCT : 0.0599 (-10.86%)
Provectus Biopharmaceuticals Announces Publication of Moffitt Cancer Center Research on PV-10 for Head and Neck Cancer GlobeNewswire - Thu Jun 26, 7:00AM CDT

PVCT : 0.0599 (-10.86%)
Provectus Biopharmaceuticals Announces Investor Webinar for 2025 Annual Meeting of Stockholders GlobeNewswire - Mon Jun 9, 7:00AM CDT

PVCT : 0.0599 (-10.86%)
Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus’s Spinoff Company for Rose Bengal-Based Eye Drugs GlobeNewswire - Tue Jan 14, 7:00AM CST

PVCT : 0.0599 (-10.86%)
VisiRose Announces $3 Million Seed Financing Round to Advance Ocular Therapeutics ACCESS Newswire - Tue Jan 14, 2:45AM CST

KNOXVILLE, TN / ACCESSWIRE / January 14, 2025 / VisiRose Inc. ("VisiRose" or the "Company"), a privately-held, clinical-stage biotechnology company developing novel ocular therapeutics, today announced...

PVCT : 0.0599 (-10.86%)
VisiRose Announces $3 Million Seed Financing Round to Advance Ocular Therapeutics ACCESS Newswire - Tue Jan 14, 2:45AM CST

KNOXVILLE, TN / ACCESSWIRE / January 14, 2025 / VisiRose Inc. ("VisiRose" or the "Company"), a privately-held, clinical-stage biotechnology company developing novel ocular therapeutics, today announced...

PVCT : 0.0599 (-10.86%)
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology GlobeNewswire - Wed Dec 11, 2024

PVCT : 0.0599 (-10.86%)
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections ACCESS Newswire - Tue Dec 10, 2024

Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals

PVCT : 0.0599 (-10.86%)
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections ACCESS Newswire - Tue Dec 10, 2024

Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals

PVCT : 0.0599 (-10.86%)

Barchart Exclusives

5 "Best of the Best" Dividend Stocks to Own in 2026 Barchart - Fri Dec 19, 6:00PM CST
These five companies come with above-average yields and buy ratings from Wall Street analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot